KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Change in Receivables (2020 - 2025)

Organon (OGN) has 6 years of Change in Receivables data on record, last reported at -$160.0 million in Q4 2025.

  • For Q4 2025, Change in Receivables rose 53.08% year-over-year to -$160.0 million; the TTM value through Dec 2025 reached -$79.0 million, up 79.37%, while the annual FY2025 figure was -$79.0 million, 79.37% up from the prior year.
  • Change in Receivables reached -$160.0 million in Q4 2025 per OGN's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $332.0 million in Q2 2021 and bottomed at -$341.0 million in Q4 2024.
  • Average Change in Receivables over 5 years is $7.5 million, with a median of $4.0 million recorded in 2021.
  • The widest YoY moves for Change in Receivables: up 866.67% in 2024, down 1362.96% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$99.0 million in 2021, then surged by 104.04% to $4.0 million in 2022, then surged by 575.0% to $27.0 million in 2023, then plummeted by 1362.96% to -$341.0 million in 2024, then surged by 53.08% to -$160.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$160.0 million in Q4 2025, $5.0 million in Q3 2025, and -$9.0 million in Q2 2025.